Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mRNA vaccine for cancer immunotherapy
Lei Miao, Yu Zhang, Leaf Huang
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 693

Showing 1-25 of 693 citing articles:

Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Jian Liu, Minyang Fu, Manni Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 473
RNA-based therapeutics: an overview and prospectus
Yiran Zhu, Liyuan Zhu, Xian Wang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 7
Open Access | Times Cited: 369
Clinical advances and ongoing trials of mRNA vaccines for cancer treatment
Cathrine Lund Lorentzen, John B.A.G. Haanen, Özcan Met, et al.
The Lancet Oncology (2022) Vol. 23, Iss. 10, pp. e450-e458
Open Access | Times Cited: 327
CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances
Karama Makni‐Maalej, Maysaloun Merhi, Varghese Inchakalody, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 284
Targeting ferroptosis opens new avenues for the development of novel therapeutics
Shumin Sun, Jie Shen, Jianwei Jiang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 222
Lipid Nanoparticle–mRNA Formulations for Therapeutic Applications
Chang Wang, Yuebao Zhang, Yizhou Dong
Accounts of Chemical Research (2021) Vol. 54, Iss. 23, pp. 4283-4293
Open Access | Times Cited: 152
RNA modifications in physiology and disease: towards clinical applications
Sylvain Delaunay, Mark Helm, Michaela Frye
Nature Reviews Genetics (2023) Vol. 25, Iss. 2, pp. 104-122
Open Access | Times Cited: 126
Traditional herbal medicine and nanomedicine: Converging disciplines to improve therapeutic efficacy and human health
Jing Zhang, Kaili Hu, Liuqing Di, et al.
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113964-113964
Closed Access | Times Cited: 124
Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics
Yeji Lee, Michaela Jeong, Jeongeun Park, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 10, pp. 2085-2096
Open Access | Times Cited: 124
Precision treatment in advanced hepatocellular carcinoma
Xupeng Yang, Chen Yang, Shu Zhang, et al.
Cancer Cell (2024) Vol. 42, Iss. 2, pp. 180-197
Open Access | Times Cited: 120
Circular RNA cancer vaccines drive immunity in hard-to-treat malignancies
Hongjian Li, Kun Peng, Kai Yang, et al.
Theranostics (2022) Vol. 12, Iss. 14, pp. 6422-6436
Open Access | Times Cited: 119
Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines
Alexander J. Stephens, N. Burgess-Brown, Shisong Jiang
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 118
A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies
Monika Kumari, Ruei‐Min Lu, Mu‐Chun Li, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 117
Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment
Nicole Kirchhammer, Marcel P. Trefny, Priska Auf der Maur, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 670
Closed Access | Times Cited: 117
Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging
Han Na Jung, Seok‐Yong Lee, Somin Lee, et al.
Theranostics (2022) Vol. 12, Iss. 17, pp. 7509-7531
Open Access | Times Cited: 114
mRNA vaccines in disease prevention and treatment
Gang Zhang, Tianyu Tang, Yinfeng Chen, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 109
Progress on Ras/MAPK Signaling Research and Targeting in Blood and Solid Cancers
Martha Dillon, Antonio R. Lopez, Edward H. Lin, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5059-5059
Open Access | Times Cited: 107
Nanomaterials in tumor immunotherapy: new strategies and challenges
Xudong Zhu, Shenglong Li
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 107
Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer
Chenyi Luo, Peipei Wang, Siqi He, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 101
Nanomedicine for brain cancer
Sabina Quader, Kazunori Kataoka, Horacio Cabral
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114115-114115
Open Access | Times Cited: 99
Cancer Vaccine Therapeutics: Limitations and Effectiveness—A Literature Review
Mariusz Kaczmarek, Justyna Poznańska, Filip Fechner, et al.
Cells (2023) Vol. 12, Iss. 17, pp. 2159-2159
Open Access | Times Cited: 98
mRNA cancer vaccines: Advances, trends and challenges
Qing He, Hua Gao, Tan De-jiang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 7, pp. 2969-2989
Open Access | Times Cited: 96
mRNA vaccines for cancer immunotherapy
Yashavantha L. Vishweshwaraiah, Nikolay V. Dokholyan
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 94
mRNA nanomedicine: Design and recent applications
Luke J. Kubiatowicz, Animesh Mohapatra, Nishta Krishnan, et al.
Exploration (2022) Vol. 2, Iss. 6
Open Access | Times Cited: 91
mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy
Zhuoya Deng, Yuying Tian, Jianxun Song, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 87
Page 1 - Next Page

Scroll to top